Digital healthcare platform developer Trellus Health (LON: TRLS) has entered an agreement with Johnson & Johnson Health Care Systems Inc for a US pilot programme for Trellus Elevate to support severe inflammatory bowel disease. Trellus Health will receive an upfront licence fee and a monthly fee. Net cash was $8m at the end of June 2024 and the additional income could help to extend the cash runway nearer to the end of 2025. The share price jumped 416.7% to 3.1p, which is the highest it has been for nine months.
MyHealthChecked (LON: MHC) says that its phlebotomy test kits have been registered in the UK and EU. This is a step in commercialising the company’s phlebotomy service during the first half of 2025. The share price increased 15.4% to 15p.
Woundcare company Advanced Medical Solutions (LON: AMS) says there has been strong growth across the product portfolio and recent acquisitions are being integrated. The 2024 pre-tax profit is expected to be in the range of £29.2m to £29.7m. The share price improved 11.6% to 212.75p.
Oriole Resources (LON: ORR) says phase 5 diamond drilling programme at the Bibemi gold project in Cameroon is ongoing with more results expected. The maiden drilling programme at Mbe gold project in Cameroon commenced at the end of 2024. Initial results are expected later in this quarter. A joint venture agreement is being drafted for the Senala gold project in Senegal. The share price rose 9.5% to 0.26p.
FALLERS
Thruvision (LON: THRU) shares slumped 53.9% to 3p after the security technology supplier announced a strategic review. Management believes that additional funding will be required to scale up the business. There is currently cash of £1.5m, which will last until May unless potential orders are secured. The cost base will be assessed. Alternatives include bringing in a partner or selling the business.
Broadcast technology developer Pebble Beach Systems (LON: PEB) says trading has been tough and Cavendish has cut its 2024 forecast revenues by 14% to £11.5m, which is 7% lower than the previous year. Flat revenues are forecast for the next two years. Pre-tax profit is set to fall from £1.7m to £1.1m in 2024 before recovering to £1.9m in 2025. Cash generation is the focus, and net debt should decline to £1.2m at the end of 2025. The share price declined 18% to 8p.
Gfinity (LON: GFIN) returned from suspension yesterday afternoon following the publication of 2023-24 results and the share price is continuing to fall today. The first stage of transformation is complete. The share price dipped 15.3% to 0.0525p and it is 30% lower since trading restarted.
Michael Ashcroft wants data and information publisher Merit Group (LON: MRIT) to leave AIM. This follows his success in persuading Jaywing (LON: JWNG) to back his AIM cancellation plan. He owns 42% of Merit Group, so he has a high chance of success. A general meeting will be set within 21 days. The share price fell 13.1% to 26.5p.
The estate of William Black has taken the opportunity to increase its stake in downhole oil and gas technology developer Enteq Technologies (LON: NTQ) from 17% to 21.8% following the slump in the share price due to delays testing of the SABER rotary tool. Even so, the share price slipped a further 6.25% to 0.825p.